Ameritox Contracts with Aetna for Prescription Drug Monitoring Services

Ameritox, the nation’s leader in pain prescription monitoring, announced today that they have entered into an agreement with Aetna to offer Aetna’s network of providers nationwide with easy access to Ameritox’s pain medication monitoring process.

Ameritox’s patented Rx Guardian^SM methodology is the only pain medication monitoring process that uses a patented methodology to help physicians assess whether patients are taking their pain medication consistent with the prescribed dosage. Ameritox provides physicians and other prescribers with valuable information and a wide range of tools to help them better manage their patients’ chronic pain and to help mitigate risks associated with non-compliance, diversion and more.

Under the agreement, Ameritox will provide laboratory analyses for a broad range of drugs and metabolites using state-of-the-art equipment, such as multiplexing liquid chromatography–tandem mass spectrometry (LC/MS/MS); the patented Rx Guardian methodology, which compares expected ranges to a normalized value based upon each patient’s prescription regimen and other individual data; detailed Rx Guardian Reports that not only indicate in-range and out-of-range results, but also include a toxicologist’s explanation of the potential sources of detected compounds; and a Toxicology Hotline offering individual consultations to prescribers.